Rye Brook, New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. II (Nasdaq: SAMA) (the “Company”) today announced that it will redeem all of the outstanding...
RYE BROOK, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”...
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Clever Leaves International Inc. (“Clever Leaves”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, held...
NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Clever Leaves (“Clever Leaves”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced it has...
RYE BROOK, N.Y., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”...
RYE BROOK, N.Y., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”...
NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Clever Leaves International Inc. (“Clever Leaves”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids...
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Clever Leaves International Inc. (“Clever Leaves”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, has...
RYE BROOK, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”...
Enterprise Value Reduction of 20% Provides Greater Value to ShareholdersPeer Comp EBITDA Multiples Have Increased 20% Since Initial Transaction Announcement Significant Reduction in the Minimum...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales